Pasithea Therapeutics Corp. Warrant (KTTAW) Financials

KTTAW Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 30.7 million 2.3 million
June 30, 2023 38.1 million 2.6 million
March 31, 2023 42.0 million 2.9 million
Dec. 31, 2022 45.2 million 2.7 million

KTTAW Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -2.6 million 126674
June 30, 2023 -3.5 million 218634
March 31, 2023 -3.3 million 177021
Dec. 31, 2022 -6.2 million 156174

KTTAW Net Income

No data available :(

KTTAW Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 19.6 million - 385288
June 30, 2023 26.6 million - 425760
March 31, 2023 29.9 million - 465454
Dec. 31, 2022 33.1 million - 926887

KTTAW Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 25.2 million
June 30, 2023 26.1 million
March 31, 2023 26.1 million
Dec. 31, 2022 25.3 million

KTTAW Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 22659 1.6 million 2.2 million -
June 30, 2023 3108 2.0 million 1.8 million -
March 31, 2023 53888 1.1 million 2.1 million -
Dec. 31, 2022 1.8 million 1.4 million 3.9 million -

KTTAW Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 162256
June 30, 2023 - 163217
March 31, 2023 - 162680
Dec. 31, 2022 240712 1308

KTTAW

Price: $0.02

52 week price:
0.02
0.02

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 3000

Market Capitalization: 25329

Links: